A novel drug has been developed for treating cancers caused by receptor tyrosine kinase (RET). BLU-667 drug is the novel, investigational drug, which was chosen as it is 100 times more selective for RET-driven cancers.
from Medindia Health News https://ift.tt/2HCxY9l
No comments:
Post a Comment